18 Jan Sangamo Therapeutics
Mark McClung, Executive Vice President and Chief Operating Officer
April 21 | 11:15am | Gaudi 3 Ballroom
Sangamo Therapeutics is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today’s medicine can only offer symptom management at best. Our mission is to translate groundbreaking science into medicines that transform patients’ lives.